These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 78993)

  • 21. Endoscopic ureteroneocystostomy: palliative urinary diversion in advanced prostatic cancer.
    Chefchaouni MC; Flam TA; Pacha K; Thiounn N; Zerbib M; Debré B
    Tech Urol; 1998 Mar; 4(1):46-50. PubMed ID: 9568777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of ureteral obstruction in primary cervical cancer.
    Lee SK; Jones HW
    Int J Gynaecol Obstet; 1994 Jan; 44(1):59-65. PubMed ID: 7907060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of percutaneous nephrostomy in malignant ureteric obstruction.
    Wilson JR; Urwin GH; Stower MJ
    Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [On malignant obstructive uremia].
    Sesenna R; Bartolotta G; Brunetti A
    Arch Ital Urol Nefrol; 1970; 43(1):7-16. PubMed ID: 5495712
    [No Abstract]   [Full Text] [Related]  

  • 25. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
    Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
    BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical studies on 61 patients with post-renal acute renal failure caused by ureteral obstruction].
    Higa I; Imagawa A
    Hinyokika Kiyo; 1987 Jul; 33(7):1005-10. PubMed ID: 3687622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.
    Barton DP; Morse SS; Fiorica JV; Hoffman MS; Roberts WS; Cavanagh D
    Obstet Gynecol; 1992 Nov; 80(5):805-11. PubMed ID: 1407920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation therapy palliation in malignancy-associated ureteral obstruction.
    Ampil FL
    Radiat Med; 1989; 7(6):282-6. PubMed ID: 2483756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-year outcome after urinary diversions in patients with obstructive uropathy.
    Takeda K; Harada A; Hirakata H; Fujimi S; Oh Y; Fujishima M
    Nephron; 1998; 78(2):246-8. PubMed ID: 9496756
    [No Abstract]   [Full Text] [Related]  

  • 30. Transvesical Suprapubic Externalization of Ureteral Stents - Introduction of a Surgical Innovation at the Development Stage.
    Gerullis H; Schwartmann K; Ecke TH; Georgas E; Herberg P; Winter A; Wawroschek F; Barski D; Otto T
    Urol Int; 2017; 99(1):69-76. PubMed ID: 28222442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reassessment of circle tube nephrostomy in advanced pelvic malignancy.
    Kohler JP; Lyon ES; Schoenberg HW
    J Urol; 1980 Jan; 123(1):17-8. PubMed ID: 7351714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined antegrade and retrograde endoscopic approach for the management of urinary diversion-associated pathology.
    Delvecchio FC; Kuo RL; Iselin CE; Webster GD; Preminger GM
    J Endourol; 2000 Apr; 14(3):251-6. PubMed ID: 10795614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Results of ureterocystoneostomy for inner urinary diversion in locally advanced prostate carcinoma].
    Wawroschek F; Hamm M; Rathert P
    Urologe A; 1998 Jul; 37(4):372-6. PubMed ID: 9738288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lethal complications of standard self-retaining ureteral stents in patients with ileal conduit urinary diversion.
    Walther PJ; Robertson CN; Paulson DF
    J Urol; 1985 May; 133(5):851-3. PubMed ID: 2580996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephrostomy in patients with ureteral obstruction secondary to nonurologic malignancy. Obstructive uropathy in malignant disease.
    McNamara TE; Butkus DE
    Arch Intern Med; 1980 Apr; 140(4):494-7. PubMed ID: 7362379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
    Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
    J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The results of the percutaneous treatment of obstructed ureteral diversions. The technic and personal experience in 46 cases].
    Cesarani F; Righi D; Cavalot G; Gandini G
    Radiol Med; 1990 May; 79(5):513-9. PubMed ID: 2359860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rationale of urinary diversion in cancer patients.
    Holden S; McPhee M; Grabstald H
    J Urol; 1979 Jan; 121(1):19-21. PubMed ID: 83395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parallel second stent placement for refractory ureteral stent malfunction in malignant ureteral obstruction.
    Chen HC; Shen SH; Wang JH; Huang WJ; Tseng HS; Chang PY; Chang CY
    J Vasc Interv Radiol; 2011 Jul; 22(7):1012-6. PubMed ID: 21571544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The ureter in urinary diversion].
    da Pozzo GP; Simeone C; Zambolin T; Cancarini G; Magri V; Aulenti V; Tosana M
    Arch Ital Urol Nefrol Androl; 1993 Mar; 65(1):53-8. PubMed ID: 8475394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.